Company continues to focus on upcoming results from ENLIGHTEN 2 pivotal Phase 3 trial in CRS patients, expected in 2Q 2025; In parallel, the Company continues to analyze data and ...
Explore the free popular stock market courses in 2025 to learn investing, trading strategies, and market analysis. Perfect ...
Looking for effective ways to protect your money right now? Here are three savings accounts to consider opening.
Financially, Annexon has a strong cash position, providing a runway of 5-8 quarters, but the stock trades almost at cash due ...
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support for the proposed primary efficacy endpoint of reduction in bloodstream inf ...
Dr.Pankaj Sharma was born into a middle-class family in India full of love and hope. His parents are both educators who know ...
The second group, so-called "Constrained Losers," are those hard-to-short stocks that have lost the most over the trailing year. The professors found that these stocks also lag the market, but for a ...
Recent FDA feedback received on SER-155 allogeneic hematopoietic stem cell transplant (allo-HSCT) next study provides support ...
The stock market is nothing if not volatile these days. When it takes a dip, a well-managed, properly diversified portfolio ...
Ideas that emerged from the University of Chicago in the 1960s changed the world. But as a new film shows, they almost didn’t ...
Another horrible day in the stock market yesterday, but don’t worry: The president is on the case. Politico shares that Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback